ZyVersa Therapeutics Inc.
(ZVSA)
undefined
undefined%
At close: undefined
1.02
-2.88%
After-hours Dec 13, 2024, 04:19 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | - | - | - | - |
Cost of Revenue | 10.40K | 10.40K | 10.40K | 10.40K |
Gross Profit | -10.40K | -10.40K | -10.40K | -10.40K |
Operating Income | -14.42M | -13.01M | -7.70M | -11.83M |
Interest Income | - | 427.54 | 821.37 | 516.45 |
Pretax Income | -107.75M | -14.05M | -8.08M | -12.68M |
Net Income | -98.30M | -759.10M | -8.91M | -13.20M |
Selling & General & Admin | 11.20M | 7.61M | 5.58M | 5.36M |
Research & Development | 3.21M | 5.41M | 2.12M | 6.47M |
Other Expenses | - | - | - | - |
Operating Expenses | 14.41M | 13.01M | 7.70M | 11.83M |
Interest Expense | -457.00K | 427.54K | 821.37K | 516.45K |
Selling & Marketing Expenses | -11.20B | - | - | - |
Cost & Expenses | 14.42M | 13.01M | 7.70M | 11.83M |
Income Tax | -9.46M | 745.05M | 821.37K | 516.45K |
Shares Outstanding (Basic) | 97.50K | 25.95K | 46.55K | 46.55K |
Shares Outstanding (Diluted) | 97.50K | 25.95K | 46.55K | 46.55K |
EPS (Basic) | -1.09K | -930.25 | -173.66 | -272.45 |
EPS (Diluted) | -1.09K | -930.25 | -173.66 | -272.45 |
EBITDA | -107.74M | -11.67M | -7.25M | -12.16M |
Depreciation & Amortization | 10.40K | 10.40K | 10.40K | 10.40K |